FDA — authorised 29 August 2012
- Application: BLA125294
- Marketing authorisation holder: SICOR BIOTECH
- Local brand name: GRANIX
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Granix on 29 August 2012
Yes. FDA authorised it on 29 August 2012.
SICOR BIOTECH holds the US marketing authorisation.